Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalyst Pharm Inc
(NQ:
CPRX
)
19.87
-0.04 (-0.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Catalyst Pharm Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Nikola, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 14, 2022
U.S. stock futures traded higher this morning ahead of the PPI data for August. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why Catalyst Pharmaceuticals Shares Are Popping Off
September 13, 2022
Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) shares are trading higher by 6.40% to $16.12 Tuesday after it was announced the company will join the S&P SmallCap 600.
Via
Benzinga
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
Via
Benzinga
Piper Sandler Increases Catalyst Pharma's Price Target Slightly After Q4 Earnings
March 17, 2022
Via
Benzinga
Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday
September 13, 2022
U.S. stocks traded lower, with the Dow Jones tumbling more than 800 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket
September 13, 2022
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 12, 2022
Gainers OpGen (NASDAQ:OPGN) shares rose 20.6% to $0.52 during Monday's after-market session. This security traded at a volume of 927.4K shares come close, making up 324.6% of its average volume over...
Via
Benzinga
Sage Therapeutics Stock Scores Relative Strength Rating Upgrade
September 09, 2022
On Friday, Sage Therapeutics stock received a positive adjustment to its Relative Strength (RS) Rating, from 86 to 91.
Via
Investor's Business Daily
Amylyx Pharmaceuticals Stock Sees Relative Strength Rating Rise To 98
September 09, 2022
Amylyx Pharmaceuticals stock hit a key technical milestone, seeing its Relative Strength Rating improve to 98, up from 83 the day before.
Via
Investor's Business Daily
Agios Pharmaceuticals Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
September 02, 2022
Agios Pharmaceuticals stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 65 to 93.
Via
Investor's Business Daily
Legend Biotech Stock Joins Elite Club Of Stocks With RS Ratings Over 90
September 01, 2022
On Thursday, Legend Biotech stock had its Relative Strength (RS) Rating upgraded to 91, up from 87 a day earlier.
Via
Investor's Business Daily
Intercept Pharmaceutical Stock Shows Market Leadership; Earns 92 RS Rating
August 30, 2022
On Tuesday, Intercept Pharmaceutical stock had its Relative Strength Rating upgraded to 92, up from 89 a day earlier.
Via
Investor's Business Daily
15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome
August 30, 2022
Not all shares are slowing down alongside the industry group.
Via
Investor's Business Daily
Relay Therapeutics Stock Shows Market Leadership With Jump To 94 RS Rating
August 25, 2022
Relay Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 84 to 94.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022
August 24, 2022
Via
Benzinga
Kymera Therapeutics Stock Scores Rising Relative Price Strength
August 22, 2022
Kymera Therapeutics stock hit a key performance benchmark, with its Relative Strength Rating upgradedjulie mak to 94.
Via
Investor's Business Daily
Rocket Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
August 11, 2022
On Thursday, Rocket Pharmaceuticals stock received an upgrade to its Relative Strength (RS) Rating, from 88 to 94.
Via
Investor's Business Daily
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 10, 2022
Gainers
Via
Benzinga
Catalyst Pharmaceuticals: Q2 Earnings Insights
August 09, 2022
Catalyst Pharmaceuticals (NASDAQ:CPRX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Catalyst Pharmaceuticals Shares Are Moving Today
August 09, 2022
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 1.47% at $10.71. Traders and investors are watching for the company’s second-quarter earnings report, confirmed for Tuesday’s...
Via
Benzinga
Kura Oncology Stock Joins Rank Of Stocks With RS Ratings Over 90
August 08, 2022
On Monday, Kura Oncology stock had its Relative Strength (RS) Rating upgraded to 91, up from 85 a day earlier.
Via
Investor's Business Daily
A Preview Of Catalyst Pharmaceuticals' Earnings
August 08, 2022
Catalyst Pharmaceuticals (NASDAQ:CPRX) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement.
Via
Benzinga
Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022
July 26, 2022
The Company Will Host a Conference Call and Webcast on August 10, 2022, at 8:30 AM ET
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
6 Best-Performing Robinhood Stocks Of 2022
May 06, 2022
The SPDR S&P 500 ETF Trust (NYSE: SPY) is off to a brutal start to 2022, down 12.1% year-to-date. Robinhood Markets Inc (NASDAQ: HOOD) has been one of the worst performers of all so far this year,...
Via
Benzinga
7 Smart Stocks to Buy Now Under $10
April 05, 2022
There are always good stocks to buy somewhere. What you should be focused on is finding the smart stocks that add value to your portfolio.
Via
InvestorPlace
This Coal Company's 1-Year Return Handily Beats Moderna, Catalyst Pharmaceuticals, Globalstar And Dogecoin
March 26, 2022
Alpha Metallurgical Resources Inc (NYSE:AMR) is known as a le...
Via
Benzinga
Catalyst Pharmaceuticals's Return On Capital Employed Insights
March 17, 2022
According to Benzinga Pro data Catalyst Pharmaceuticals (NASDAQ:CPRX) posted a 9.88% decrease in earnings from Q3. Sales, however, increased by 6.55% over the previous quarter to...
Via
Benzinga
Recap: Catalyst Pharmaceuticals Q4 Earnings
March 16, 2022
Catalyst Pharmaceuticals (NASDAQ:CPRX) reported its Q4 earnings results on Wednesday, March 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.